Evaluation of an antimalaria combined with praziquantel for treating Kenya children with intestinal or urogenital bilharzia in Homabay County
- Conditions
- schistosomiasis
- Registration Number
- PACTR202211501227743
- Lead Sponsor
- Kenya Medical Research Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 702
•Aged between 6 and 15 years old (confirmed from the date of birth recorded on the school registers),
•Study participants appear healthy at enrollment, as assessed by the study clinician
• Suffering from S. mansoni or S. haematobium infection
•Residing in Homabay county
•Able to take oral treatment,
•Respective parent/ guardian gives informed consent for the child to participate in the study
•Child assent to participate in study
•Weighing more than 50 kg,
•Pregnant or lactating at the time of the study,
•Presence of infection with Plasmodium falciparum or other Plasmodium spp.
•Presence of severe illness, such as cerebral cysticercosis,
•Signs of severe malnutrition
•Hypersensitivity to Artesunates, sulfonamides or praziquantel.
•Use of another anti-malaria or anti-schistosomal drug during the study, or within 28 days before the administration of the study treatment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method